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In an earlier study we found that pigtailed macaques (Macaca nemestrina) that were experimentally infected with human
immunodeficiency virus type 1 (HIV-1) initially became viremic and seroconverted, but HIV-1 replication diminished markedly
over time. In an attempt to develop a longer term pathogenic model, blood from HIV-1-infected macaques was serially
transfused into three groups of naive macaques. Transfer was successful through two transfusions as shown by repeated
virus isolations and confirmed by the development of cell-free plasma viremia and by seroconversion. Three to five weeks
after transfusion, plasma levels of HIV-1 RNA from several macaques in the first two groups exceeded those of the initially
inoculated macaques. However, animals in the third group had diminished RNA levels, were virus culture negative, and did
not seroconvert. Sequence analyses of env-region clones from infected animals revealed only minimal changes over the
course of the passages. These results confirm HIV-1 replication in M. nemestrina during the acute phase of infection.
However, adaptation of HIV-1 to a macaque-pathogenic variant did not occur during serial passage, possibly because the
animals were able to restrict HIV-1 replication below a level required for a pathogenic variant to emerge. Whether such
containment is a function of the host’s immune response or a virus cell incompatibility remains to be determined. q 1997
Academic Press
INTRODUCTION mained virus reisolation negative over 4.5 years, sug-
gesting continued viral replication at a site remote from
Experimental infection of pigtailed macaques (Macaca the peripheral circulation. In some animals we have de-
nemestrina) with human immunodeficiency virus type 1 tected HIV-1 DNA in lymph nodes and spleen up to 84
(HIV-1) was first described by our research group (Agy et weeks p.i. (unpublished data). Proviral DNA has been de-
al., 1992; Frumkin et al., 1993) and later confirmed by tected in brain tissue of HIV-1-infected macaques at 60
Gartner et al. (1994a,b). The laboratory-adapted strains of weeks p.i. but no viral RNA could be detected in these
HIV-1 used in our laboratory were LAI (Barre-Sinoussi et animals by RNA polymerase chain reaction (PCR) (Frum-
al., 1983; Wain-Hobson et al., 1991) and the closely related kin et al., 1995). The sequence of the V3 region of the
molecular clone, NL4-3 (Adachi et al., 1986). Infection re- provirus detected in the brain had not diverged from that
sulted in seroconversion of the animals by 2 to 3 weeks, of the inoculum (HIV-1LAI), indicating limited in vivo proviraland virus was routinely reisolated during the first 2 months genetic variation in that region of the genome. Such an
following inoculation. After 2 months, virus reisolation at- interpretation is consistent with very low virus replication
tempts were generally unsuccessful. HIV-1 infections of (Frumkin et al., 1995).
M. nemestrina have not been associated with declines in Primate lentiviruses capable of efficient replication are
CD4/ T-cells, nor have they been associated consistently usually pathogenic, cause host cell destruction (CD4/ T-
with any clinical signs of immunodeficiency disease. Oc- cell depletion), and lead to the development of immuno-
casionally, virus has been recovered late after infection. deficiency disease. In this report we describe an experi-
For example, Gartner et al. (1994a) reisolated HIV-1 from mental effort designed to accelerate the adaptation of
an infected pigtailed macaque 68 weeks postinoculation HIV-1 in M. nemestrina by serial in vivo passage of in-
(p.i.), and we have recovered HIV-1 from two macaques fected blood. Serial in vivo passage from infected to naive
at 24 weeks p.i. Most animals retain virus-specific immu- macaques has been used successfully to produce highly
noblot reactivity to HIV-1 antigens. We have followed two pathogenic primate lentiviruses such as SIVMACPBJ14macaques that have remained immunoblot positive, with (Fultz et al., 1989), HIV-2287 (McClure et al., 1994), andantibodies to gag and env, for 5 years after a single HIV- SHIVHXBc2 chimera (Joag et al., 1996). All of these viruses1 inoculation (unpublished data). These animals have re- were originally reisolated from serially infected M. nem-
estrina. More recently, SHIV 89.6 was serially passed in
M. mulatta, producing an acutely pathogenic virus (89.6P)1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (206) 685-0305. E-mail: magy@u.washington.edu. (Reimann et al., 1996). We were able to pass the HIV-1
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infection through two sets of animals as determined by 4 M guanidinium thiocyanate. Complimentary DNA (cDNA)
was then synthesized from the purified sample RNA andRNA-PCR, virus recovery, and serology but were unable
to detect evidence of enhanced pathogenicity. added to competitive template RNA with the use of random
hexamers and Moloney murine leukemia virus reverse
transcriptase in reaction buffer containing rRNasin. EqualMATERIALS AND METHODS
copy numbers of competitive template, transcribed from
Macaques, virus stocks, and transfusion regimens plasmid pQP1D80 (Piatak et al., 1993), were added to 0.5
log10 serially diluted test RNA samples. Following synthe-The macaques used in this study were Macaca nem-
sis, the cDNAs were amplified by PCR with the use of gag-estrina leonina (Fooden, 1975), descendants of animals
specific primers: GAG-06, 5*-GCITTIAGCCCIGAAGTIATA-that were captured in Viet Nam and later obtained from
CCCATG and GAG-04, 5*-CATICTATTTGTTCITGAAGG-the Medical Institute of Primatology in Sochi, Russia. The
GTACTAG. After denaturation incubation at 947 for 60 s,ancestry is similar to the more common M. nemestrina
the specific gag regions were amplified in a thermocyclernemestrina; both subspecies have similar habitats and
during 35 incubation cycles of 947 for 23 s, 607 for 23 s,come from overlapping geographical ranges (Fooden,
and 727 for 30 s; finally, they were incubated at 727 for 51975).
min. A conserved internal region of the amplified productsThe infected macaques were housed in the biosafety
was hybridized in solution to a 32P-labeled oligonucleotide:level 3 facility at the Washington Regional Primate Re-
5*-CCAGGCCAGATGAGAGAACCAAGGG. Each hybridiza-search Center, where they were maintained in compli-
tion mixture contained 2.51 105 CPM. The hybridized prod-ance with standards set forth in The Guide for Care and
ucts were resolved on 6% polyacrylamide gels and visual-Use of Laboratory Animals by the Institute of Laboratory
ized by autoradiography. When the initial assay revealedAnimal Resources Commission on Life Sciences, Na-
copy levels below 1000 per ml, serial 10-fold dilutions weretional Research Council. The WaRPRC is fully accredited
made and rerun with the level being the lowest dilution inby the American Association of Laboratory Animal Care
which the signal was consistently detected. QuantitationInternational. For invasive procedures such as intrave-
was achieved by comparing paired signal intensities fromnous injections and blood collection, the animals were
paired samples and pQP1D80 cDNAs on the autoradio-sedated with ketamine hydrochloride (10 mg/kg body
graphs. Studies with HIV-1 gag RNA indicated a sensitivityweight).
of 10 copies.The inoculating virus stocks were prepared as de-
scribed previously (Agy et al., 1990, 1992). The experi-
mental design is shown in Fig. 1. Macaques in group 1 Cloning and sequencing
were inoculated with 1 1 107 tissue culture infectious
Cell pellets of PBMC from infected animals or tissuedose (TCID) HIV-1-infected autologous peripheral blood
culture were lysed in 100 ml proteinase K buffer andmononuclear cells (PBMC) suspended in 1 ml of virus
incubated at 657 for 45 min. After the proteinase K wasstock containing 1 1 107 TCID HIV-1LAI or 1 1 106 TCID
inactivated by incubation at 957 for 15 min, 2 ml of theHIV-1NL4-3 . Macaques in groups 2 and 3 were inoculated
DNA preparation was used as substrate in a nested PCRintravenously with blood and PBMC and the two animals
amplification. An initial PCR using primers ENV-1, 5*-in group 4 received blood only.
(GTCTATTATGGGGTACCTGTGTGG) and ENV-3, 5*-
(CACTTCTCCAATTGTCCCTC) was carried out to amplifyVirus cocultures
a fragment of approximately 1330 base pairs (bp) con-
PBMC were purified from anticoagulated macaque taining most of the coding region for the gp120 surface
blood on Ficol density gradients. Macaque cells were glycoprotein. A 300-bp internal region spanning the V1
cocultured with phytohemagglutinin (PHA)-stimulated hu- and V2 regions contained in the initial reaction product
man PBMC at a 2:1 ratio. Usually 1 1 107 macaque cells was further amplified using primers ENV-4 (GGATCA-
were used. The cultures were maintained weekly by the AAGCCTAAAGCCATG) and ENV-5 (AGGCCTGTGTAA-
addition of fresh medium and 3 1 106 PHA-stimulated TGACTGA). A 270-bp fragment spanning the V3 region
human PBMC. Coculture supernatants were assayed by was amplified separately using primers ENV-6, 5*-(GCT-
antigen capture enzyme-linked immunosorbent assay AAAACCATAATAGTACAGCTG) and ENV-8, 5*-(TTTCTG-
(ELISA) to detect HIV-1 antigen production. Positive GGTCCCCTCCTGAGG). Following denaturation at 947 for
ELISA results were confirmed the following week and 15 min, the initial 100-ml reaction mixtures were amplified
negative cultures were maintained for 6 weeks. during 30 cycles of incubation at 957 for 1 min, 557 for 1
min, and 727 for 2 min. The nested reactions were carriedQuantitative PCR
out in a 50-ml reaction volume during 30 cycles of incuba-
tion at 957 for 1 min, 607 for 45 s, and 727 for 1 min.HIV-1 RNA levels in plasma were determined by a modi-
fication of a protocol developed by Piatak et al. (1993). To determine the role of Taq polymerase error in our
PCR-cloning strategies, we used the assay described byBriefly, total RNA was extracted from 100 ml of plasma in
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FIG. 1. Experimental design. The macaques (identified in the rectangles), their respective groups (indicated along the top), and the relative times
of transfusion are shown. The macaques in group 1 were infected with cell-free and cell-associated HIV-1LAI (93086) or HIV-1NL4-3 (93089). Macaques
in groups 2 and 3 were inoculated with 10 ml of blood supplemented with 1–1.5 1 107 PBMC from the autologous donor from a previously virus-
positive time point. The added cells had been viably frozen until injected. Macaques in group 4 were inoculated with 10 ml of blood only.
Andeweg et al. (1992). Briefly, a 7-kb plasmid containing RESULTS
the 16.1 HIV-1 env gene was examined in the PCR de-
In this experiment we used HIV-1NL4-3 and HIV-1LAI , twoscribed above. Twelve 16.1 PCR-derived clones using
closely related laboratory-adapted virus isolates knownprimer pairs ENV4/5 or ENV6/8 were sequenced and
to produce acute infection in M. nemestrina. The experi-compared with the original sequence of 16.1. The prod-
mental design is shown schematically in Fig. 1. Initially,ucts of each PCR were cloned by means of the Promega
we confirmed that PBMC from M. nemestrina leoninapGEM-T vector kit following the manufacturer’s instruc-
supported HIV-1 replication in vitro. The two animals intions. Up to 12 clones were picked from each PCR and
Group 1 were inoculated with cell-associated and cell-the plasmid inserts were sequenced with the use of
free virus (one with HIV-1NL4-3 and one with HIV-1LAI). AtSequenase (Amersham) following the manufacturer’s in-
4 weeks, 10 ml of whole blood and 15 million autologousstructions for sequencing of double-stranded plasmid
PBMC (viably frozen from the week 2 samples) from eachDNA. All sequences were analyzed by means of the Gene-
animal were inoculated into the macaques in group 2.works software package (Intelligenetics). To assess the
After 7 weeks, blood and cells from the two virus-positivesignificance of the viral variation detected in this PCR
animals in group 2 (HIV-1NL4-3 recipients) were transfusedapproach, we also amplified and sequenced up to 12
into the four macaques in group 3. In the final transfusion,fragments obtained through amplification reactions of the
two macaques in group 4 were inoculated with 10 ml ofHIV-1 proviral clone HXB-2, obtained from the AIDS Re-
blood only from macaque 93113 at week 8, which wassearch and Reference Program (Shaw et al., 1984; Po-
later determined to be a virus culture-negative time point.povic et al., 1983). The amount of variation was compared
by means of Student’s t test.
HIV-1 was recovered from macaque PBMC
cocultures up to 10 weeks posttransfusionClinical, serological, and lymphocyte subset analyses
Macaque antibodies to specific HIV-1 antigens were To determine how long transfusion recipients re-
mained viremic, and whether successive transfusion ani-detected by standard immunoblot techniques. Serially
collected serum samples were reacted with filter strips mals remained viremic for longer periods of time, we
set up virus reisolation cultures over 6 months p.i. Viruscontaining HIV-1 antigens that had been resolved via
polyacrylamide gel electrophoresis with sodium dodecyl reisolation results are summarized in Table 1. During the
first 10 weeks p.i., virus was recovered five times fromsulfate. All immunoblots were performed at the same
time on filter strips from a single manufacturer lot. Lym- the LAI-infected animal (macaque 93086) and seven
times from the NL4-3-infected animal (macaque 93089).phocyte subset analyses were performed by flow cytom-
etry on PBMC previously reacted with fluorescent anti- Both animals seroconverted by 2 to 4 weeks (Fig. 2).
Group 2 was the first transfusion recipient group. Thesebodies specific for CD4, CD8, CD20 and CD2.
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TABLE 1
Recovery of HIV-1 by Coculture Following Serial Whole Blood Transfusions
Weeks posttransfusion
Animal 1 2 3 4 5 6 7 8 10 12 14 16 20 24
Group 1
93086 0 / 0 / / / / 0 0 0 0 0 0 0
93089 / / / / 0 / / 0 / 0 0 0 0 0
Group 2
93094 0 0 0 0 0 0 0 0 0 0 0 0 0 0
93117 0 0 0 0 0 0 0 0 0 0 0 0 0 0
93088 0 0 / / / / / 0 0 0 0 0 0 0
93091 0 0 0 0 / 0 / 0 0 0 0 0 0 0
Group 3
93085 0 0 0 0 / / / / 0 0 0 0 0 0
93090 0 0 0 0 0 0 0 0 0 0 0 0 0 0
93093 0 0 0 0 0 / 0 0 0 0 0 0 0 0
93113 0 0 0 0 / / 0 0 0 0 0 0 0 0
Group 4
93112 0 0 0 0 0 0 0 0 0 0 0 0 0 0
93116 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Note. /, Positive cultures confirmed by two sequential positive HIV-1 antigen-capture assays performed on culture supernatants; 0, cultures that
remained negative for 6 weeks.
animals received blood and cells from the animals of fusions of the NL4-3 arm of the experiment. Although
infections were successfully transferred, there was nogroup 1 at 4 weeks p.i. No virus was reisolated from the
two macaques (93094 and 93117) that received material evidence to suggest that a sustained increase in the
length of time virus could be recovered from the recipientfrom the HIV-1LAI-inoculated animal and this arm of the
experiment was discontinued. Interestingly, we detected macaques.
HIV-1 antibodies in serum samples from 8 to 12 weeks
Plasma viremia provided direct evidence for HIV-1posttransfusion (Fig. 2) in these virus culture-negative
replication in transfused M. nemestrinamacaques. In contrast, HIV-1 was reisolated five times
from macaque 93088 and twice from macaque 93091,
To further monitor HIV-1 infections in M. nemestrina,
both of which received material from the HIV-1NL4-3-inocu- we examined plasma virus levels in sequential plasma
lated animal in group 1. Both animals seroconverted be-
samples. We detected HIV-1 RNA from 3 of 3 LAI-infected
tween 4 and 8 weeks after transfusion (Fig. 2).
macaques, including one virus culture-negative macaque
Seven weeks after the group 2 animals were inocu-
(93117) in group 2, from all 7 culture-positive animals
lated, the four animals in group 3 received blood and
from the NL4-3 arm of the study, and from one culture-
PBMC from the two HIV-1NL4-3-inoculated animals in negative, seronegative macaque (93116) in group 4 (Fig.
group 2. One pair, macaques 93085 and 93090, received
3). HIV-1 RNA levels of ¡10 to 10,000 copies were
material from macaque 93088. Macaque 93085 was virus
detected in plasma from 11 of 12 macaques in this study.
positive four times during the first 8 weeks (Table 1),
Peak levels preceded seroconversion. Both the NL4-3
but no virus was reisolated from macaque 93090. Both
and LAI transfusion recipient macaques in group 2 had
animals seroconverted, macaque 93085 by 8 weeks p.i.
higher peak RNA levels than those in group 1, which
and macaque 93090 by 12 weeks p.i. (Fig. 2). The other
received the initial inoculation with virus stock. However,
pair in this group, macaques 93093 and 93113, received
the increased plasma levels were not seen in plasma
blood and PBMC from macaque 93091. HIV-1 was reiso-
samples from successive transfusion recipients in
lated once from macaque 93093 and twice from macaque
groups 3 and 4.
93113 during the first 6 weeks p.i. (Table 1). Both of these
animals seroconverted between 4 and 8 weeks (Fig. 2). All of the macaques in the first three groups
The two animals in group 4 (macaques 93112 and seroconverted although none developed symptoms of
93116) received only blood from macaque 93113; transfu- immunodeficiency disease
sion occurred 8 weeks after the donor had received its
transfusion. No virus was reisolated from these animals All macaques in the first three groups seroconverted
to HIV-1. In contrast, the pair of macaques in group 4and neither seroconverted. Virus reisolation culture re-
sults confirmed transfer of virus during the first two tran- did not seroconvert and only very low levels of virus RNA
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were detected in the plasma of macaque 93116 at weeks were unable to achieve our primary objective of recovering
a highly replicative pathogenic variant of HIV-1 in M. nem-3 and 5 posttransfusion (Fig. 3). Overall, the intensity of
antisera reactivity and number of antigens that they re- estrina. HIV-1 infection and in vivo virus replication were
confirmed by virus recovery in coculture and by monitoringacted with decreased with each successive transfusion
group. None of the macaques displayed any clinical virus levels in plasma. Our results showed that each new
infection began with de novo HIV-1 particle synthesis tosigns of immunodeficiency disease, and no decline in
CD4/ T-cells was detected. peak levels during the first 2 months followed by undetect-
able virus levels in the peripheral blood through 6 months.
Sequence analyses of cloned env regions from The 4- to 6-week delay to peak virus production levels
transfusion recipients revealed little evidence strongly suggests that HIV-1 replication occurred in vivo
of HIV-1 adaptation in the macaque hosts and makes it unlikely that inoculum virus was responsible
for this time course. In addition, we noted that HIV-1Env sequence data were obtained for all macaques in
plasma RNA levels in these macaques were similar togroups 1 to 3 except macaque 93090 in group 3, which
those reported in HIV-1-infected chimpanzees (Peeters etwas virus reisolation negative (Table 1). A quantitative
al., 1995; Murthy et al., 1996).representation of the amount of variation found for HIV-
The fact that the animals in group 2 showed levels of1 DNA in the individual macaques is summarized in Ta-
plasma virus that exceeded those in the original pair ofble 2. Instances where the observed variation was statis-
macaques initially suggested enhanced replication in thetically significantly greater than expected on the basis of
transfusion recipients. However, the higher RNA copyTaq polymerase error in the PCR are indicated by an
number seen in macaque 93088 (group 2) was not repro-asterisk (*). Variation between individual fragments
duced in group 3 animals (macaques 93085 and 93090)within one macaque did not exceed 1.2%; the one excep-
that were infected with donor material from animal 93088tion was for macaque 93089 (2.1%), which was the only
(although the maximum viral RNA levels detected insample that was obtained after tissue culture. The se-
these two group 3 macaques were higher than thosequences obtained late (approximately 4 months) in the
observed in the group 1 donor, macaque 93089). Thepassage experiment in group 3 (macaques 93093 and
apparent decline in levels may be related to virus titer93113) did not differ more from the original inoculum
in the inoculum, which was directly influenced by thevirus (HIV-1NL4-3) than those early in the passage experi-
time of donation, and perhaps to the variable geneticment (macaque 93089), indicating limited genetic drift
backgrounds of the animals. Adaptation of HIV-1 to effi-(not shown). We also looked for fixation of specific muta-
ciently replicate and cause immunodeficiency diseasetions in transfer as evidence of adaptation. Most of the
in macaques will likely require virus genetic alteration,observed mutations were single point mutations found
phenotypically represented by increased virus replica-in only one of the sequenced clones, in one macaque
tion rates for longer duration. Although HIV-1 replicatesonly. Instances of mutations found in all or most clones
in M. nemestrina PBMC in vitro (Frumkin et al., 1993;from one animal, compared with the input virus, were
Gartner et al., 1994a), the levels of virus produced areobserved in animals 93091 (group 2) and 93113 (group
significantly lower than those in human cells under simi-3), as shown in Table 2. One of the mutations found in
lar conditions. Lower HIV-1 replication rates in macaqueall V3 clones from macaque 93091 was also found in
cells may prevent or limit CD4/ T-cell cytopathology.six of nine clones from macaque 93113, suggesting a
Conversely, a faster replicating HIV-1 variant might over-potential adaptive advantage for this mutation. Lack of
come a putative threshold level producing a virus popula-dramatic sequence variation in passage could be a func-
tion adapted to the macaque system capable of sus-tion of limited virus replication, but also of preferential
tained replication.infection of macaques by viruses that are genetically
Each successive transfusion resulted in infections thatsimilar to the parental NL4-3 virus.
followed a course similar to that seen in the group 1
animals with respect to virus isolation and relativeDISCUSSION
plasma RNA levels over time. Virus could be recovered
and transfused weeks after inoculation and after pas-Although we were able to pass HIV-1 infection in blood
through three serial transfusions in M. nemestrina, we sage through several animals, confirming and extending
FIG. 2. Immunoblots showing relative times to seroconversion. Immunoblots depicting seroconversion following virus inoculation (group 1) or
transfusion from infected macaques (groups 2 and 3) are shown. The blots are arranged by macaque group and the specific animal number is
shown at the base of each set of strips. The location of viral protein is shown to the left of each group. Serum samples from the weeks postinoculation
(shown below each strip) were reacted with viral proteins contained on filter paper strips from a single commercial lot. Results from a single run
are shown. The antigen–antibody complexes were visualized with standard horseradish peroxidase techniques and the positions of HIV-1 proteins
are indicated to the left of each group of strips. For comparison, the top panel shows identical strips reacted with pooled sera from humans infected
with HIV-1-infected humans, HIV-2- and SIV-infected macaques, and negative macaque sera pool.
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FIG. 3. HIV-1 gag RNA copies in the plasma of infected macaques. Gag-specific quantitative competitive RNA PCR followed by liquid hybridization
of the product with a 32P-labeled probe was used to measure the virus levels in plasma from the macaques following virus inoculation (group 1)
and transfusion (groups 2–4). Groups are indicated at the top of each panel. The panels compare plasma virus levels for individual macaques
shown in the top right portion of each panel. The horizontal line at 10 copies/ml represents the limit of detection of our assay. Gag RNA copies
are shown on the left and weeks p.i. at the bottom of each panel.
our earlier observations. Our results strengthen the no-
tion that HIV-1 actively replicates in infected pigtailed
TABLE 2 macaques. As noted previously, this replication is limited
Summaries of env Sequences (V1–V2 and V3) and replicating virus is not usually detected after 10
from NL4-3-Infected Macaques weeks. It is possible that a host response is triggered
by the acute phase of the infection, when virus replication
A. Sequence variation in HIV-1 env fragments
can be detected. We have shown previously that HIV-1-
infected pigtailed macaques produce virus-neutralizingSequence Mean diversity (%), Mean diversity (%),
source V1– V2 region V3 region antibodies Frumkin et al., 1993) and HIV-1-specific cyto-
toxic T-lymphocytes (Kent et al., 1995); these responses
93089 (Culture) 2.1* 0.6* could contribute to the repression of HIV-1 replication.
93088 (PBMC) 0.4 0.4*
Another possibility currently being examined is a poten-93091 (PBMC) 0.5 0.3*
tial role for CD8/ T-cell antiviral factor(s) previously de-93085 (PBMC) 0.7 0.8*
93093 (PBMC) 0.8* 0 scribed in humans and nonhuman primates infected by
93113 (PBMC) 1.2* 0.4* HIV-1 and by simian immunodeficiency virus and HIV
NL43 (Plasmid) 0.5 0.2 type 2 (Mackewicz et al., 1995; Cocchi et al., 1995). The
B. Mutations found in 50% of recovered env clones absence of CD4 cell decline is compatible with limited
virus replication in vivo. Clearly, a better understanding
Position in of the suppressive response to HIV-1 infection in ma-
Mutation NL43 Amino acid
caques will provide valuable insights into mechanismsAnimal Region (frequency) env change
of HIV-1 pathogenesis.
93091 V2 G c A (100%) 510 Silent
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